Paris Diderot University Study Points to Wide Benefits to Universal HCV Screening

Paris Diderot University study provided evidence that the benefits of early HCV detection and treatment outweigh the costs of treatment.  To date most HCV testing is limited to elevated risk categories relays Jared Kaltwasser of MD Magazine.
The results were clear: “Universal screening led to the lowest prevalence of CHC and incidence of events, regardless of treatment initiation.”  Kaltwasser noted that Nancy Reau, MD, an HCV specialist at Rush University Medical Center and a member of the American Liver Foundation’s National Medical Advisory Committee called out “that universal screening in the US would go a long way towards reducing stigma around HCV and identifying those in need of care.

Research/Investigative Site:

Paris Diderot University

Lead Research/Investigator:

Sylvie Dueffic-Burban, PhD...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee